Shares of scientific consulting firm Exponent (NASDAQ:EXPO) jumped in the afternoon session after UBS raised its price target on the company's stock to $81 from $76. The financial services firm kept a ...

Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...

Baron Funds, an investment management company, released its “Baron Small Cap Fund” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. A general sense of optimism was ...